David Adams

David Adams is Head of the French National Reference Centre for Familial Amyloidotic Polyneuropathy (FAP), a position held since 2005, and has been the Coordinator of the French Network for FAP (CORNAMYL) since 2010 and built the European Network for ATTR amyloidosis (ATTReuNET) in 2015. He was made a Professor of Neurology at the Université Paris Sud, France in 1996. In 2009, he became Head of the Department of Neurology Centre Hospitalier Universitaire Bicêtre (CHU), at Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Sud. His main areas of expertise are peripheral neuropathies, including FAP and other rare peripheral neuropathies. He has been particularly involved in the evaluation of the effects of liver transplantation on neuropathy in FAP patients in France since 1993, and the neurological risks of domino liver transplantation. He is Principal Investigator in many multicentric clinical trials for FAP. He is now involved in research programmes of early diagnosis in sporadic cases and genetic carriers. Professor Adams was an Advisory Board member for the International Symposium on FAP, and the International Symposium on Liver Transplantation in FAP since 2007. Professor Adams also served on the local organising committee for Biennal Peripheral Nerve Society in Saint-Malo (France) in July 2013. He organized the first European Congress for ATTR Amyloidosis the 2 and 3 november 2015 in Paris. He was elected in the board of Peripheral Nerve Society since 2015 and in the board of member of European Academy of Neurology Scientific Panel Neuropathies since 2015. Professor Adams has published 110 articles in national and international journals, including Annals of Neurology, Archives of Neurology, Brain, Current Opinions in Neurology, JACC, JNNP, Nature Reviews Drug Discovery, Neurology, New England Journal of Medicine, and PNAS.